281 related articles for article (PubMed ID: 38163978)
1. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung Cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract][Full Text] [Related]
2. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.
Liu HT; Zou YX; Zhu WJ; Sen-Liu ; Zhang GH; Ma RR; Guo XY; Gao P
Cell Death Differ; 2022 Mar; 29(3):627-641. PubMed ID: 34608273
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
4. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
5. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
6. M
Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
9. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
11. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.
Cao Y; Di X; Cong S; Tian C; Wang Y; Jin X; Zhao M; Zhou X; Li R; Wang K
Life Sci; 2023 Feb; 315():121359. PubMed ID: 36608868
[TBL] [Abstract][Full Text] [Related]
12. Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
Mao G; Mu Z; Wu DA
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1484-1494. PubMed ID: 34605863
[TBL] [Abstract][Full Text] [Related]
13. The N
Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
[No Abstract] [Full Text] [Related]
14. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway.
Liu C; Ren L; Deng J; Wang S
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897
[TBL] [Abstract][Full Text] [Related]
15. METTL3-Mediated m
Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
[TBL] [Abstract][Full Text] [Related]
16. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
17. Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163.
Qiu C; Li C; Zheng Q; Fang S; Xu J; Wang H; Guo H
Bioengineered; 2022 May; 13(5):11987-12002. PubMed ID: 35603556
[TBL] [Abstract][Full Text] [Related]
18. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
19. N
Xian J; Shang M; Dai Y; Wang Q; Long X; Li J; Cai Y; Xia C; Peng X
J Dermatol Sci; 2022 Jan; 105(1):27-36. PubMed ID: 34930676
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
Hu Y; Zhang Y; Ding M; Xu R
J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
